Fonterra’s probiotic strains, HN019 and HN001, have undergone extensive testing spanning decades, showcasing remarkable benefits for digestive and immune health.
Their supplements boast natural phospholipids, mirroring those naturally occurring in the human brain, amplifying their effectiveness. Clinical trials affirm their pivotal role in stress management, enhancing focus, and facilitating muscle recovery.
The Empower study, a groundbreaking investigation, revealed a striking 45% reduction in mean stress scores among participants supplementing with broad-spectrum phospholipids from milk fat globule membranes, compared to a mere 21% reduction in the placebo group. This finding underscores the profound impact of phospholipid supplementation on stress responses.
Recent research further supports the holistic advantages of phospholipids, demonstrating their ability to enhance stress resilience and mood. Studies indicate improved reaction times under stress and a link between phosphatidylserine consumption and reduced stress feelings, a more relaxed mood, and decreased cortisol release.
Additionally, a recent 60-day study, showcased increased happiness among consumers taking HN001, as assessed by the Oxford Happiness Questionnaire.
Moreover, ongoing validation efforts include a larger randomized controlled trial, affirming the positive results observed. Another study involving 423 women demonstrated a remarkable 1/30th reduction in the risk of postnatal depression among those taking HN001 compared to the placebo group. Additionally, a smaller study with 33 individuals with prediabetes revealed significant improvements in mental wellness with HN001 supplementation, as assessed by a Short Form 12 questionnaire.
Fonterra’s dedication to inclusivity shines through formulations suitable for diverse diets, with dairy-derived phospholipids aligning with stringent quality standards and dietary preferences.
In summary, Fonterra’s pioneering ingredients, coupled with their multifaceted formulations, cement their position as frontrunners in the cognitive health arena, addressing evolving consumer demands with precision.
Dark Chocolate: A Potential Ally Against Type 2 Diabetes
December 7, 2024
